FDA Strikes Sinusitis Indication From OTC Nasal Decongestant Products

Drug Industry Daily
KEYWORDS FDA
A A

The FDA is amending the final monograph (FM) for OTC nasal decongestant drugs to remove language indicating the products can be used to treat sinusitis, according to a final rule released Oct. 7.

To View This Article:

Login

Subscribe To Drug Industry Daily